Ignacio J. Amat‐Santos

100.13 Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to the Randomized Multivessel Talent Trial

TCT-937 Short-term and Long-term forecasting of clinical events in the Multivessel TALENT Trial with de novo three vessel coronary artery disease population

TCT-1081 Renal Function-Stratified Comparison of Complete vs. Culprit-Only Revascularization in Older Patients with Myocardial Infarction and Multivessel Disease

Contemporary Use of Coils During Percutaneous Coronary Intervention: Insights From the Multicenter COILSEAL Registry

Angioplasty‐Assisted, Suture‐Mediated Vascular Closure Enabling Percutaneous Transfemoral TAVR in Case of a Diseased Puncture Site. The FEM‐PREP Technique

Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves

Performance of Purpose-Built vs Off-Label Transcatheter Devices for Aortic Regurgitation

Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis

Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes

TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale

Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology

Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR

Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real‐world multicentre experience

Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry

Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality

Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement

Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR

Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial

Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement

Third-Generation Balloon and Self-Expandable Valves for Aortic Stenosis in Large and Extra-Large Aortic Annuli From the TAVR-LARGE Registry

Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study

Infective Endocarditis Following Transcatheter Aortic Valve Replacement

Valve-in-Valve Implantation Using the ACURATE Neo in Degenerated Aortic Bioprostheses

Arrhythmic Burden as Determined by Ambulatory Continuous Cardiac Monitoring in Patients With New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement

Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement

Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation

Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement

Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death